Dergiler / Cyprus Journal of Medical Sciences / 2021 / Cilt: 6 - Sayı: 3

Canavan Disease and Recent Advances

Sayfa
273–278
DOI
—
🏛️Bu makalenin bibliyografik verileri ve tam metin bağlantısı DergiPark üzerinden sağlanmıştır.
DergiPark Kaydı ↗
✨

Yapay Zeka Hızlı Bakış & Çıkarımlar

AI Insight
⚡ TL;DR(1 Cümlede Hızlı Çıkarım)

Among these diagnostic approaches, the NAA peak detected with the use of MRS is highly characteristic of CD and is the cornerstone in early diagnosis.

📌 3 Maddede Bu Makale

🎯
Amaç & Hipotez:Canavan disease (CD) is a rare autosomal recessively inherited leukodystrophy.
📊
Temel Bulgular & Veri:The current diagnostic approach to identify CD cases includes the demonstration of increased urinary NAA level, diminished or absence of enzyme activity in cultured skin fibroblasts, the loss of white matter including U-fibers in magnetic resonance (MR) imaging, NAA peak in MR spectroscopy (MRS), and genetic testing, in which more than 70 mutations have been identified.
💡
Sonuç & Katkı:Among these diagnostic approaches, the NAA peak detected with the use of MRS is highly characteristic of CD and is the cornerstone in early diagnosis.
🔬Tür:Araştırma Makalesi
📍Kapsam:Genişletilmiş Akademik Örneklem
⚙️Değişkenler:Alan Parametreleri

Özet

Canavan disease (CD) is a rare autosomal recessively inherited leukodystrophy. The genetic defect related to the aspartoacylase gene. The clinical characteristics of CD include hypotonia, macrocephaly, developmental delay, and visual impairment within the first year of life. There is currently no cure for CD, however, new therapeutic modalities and gene therapy options are under investigation. Possible mechanisms in the pathogenesis include astrocytic edema caused by N-acetyl-L-aspartic acid (NAA) serving as a water pump and diminished acetate that is required for myelin synthesis. The current diagnostic approach to identify CD cases includes the demonstration of increased urinary NAA level, diminished or absence of enzyme activity in cultured skin fibroblasts, the loss of white matter including U-fibers in magnetic resonance (MR) imaging, NAA peak in MR spectroscopy (MRS), and genetic testing, in which more than 70 mutations have been identified. Among these diagnostic approaches, the NAA peak detected with the use of MRS is highly characteristic of CD and is the cornerstone in early diagnosis.

🔖

Bu Makaleye Atıf Yap

DİRİK, M., ŞANLIDAĞ, B., DİRİK, E., BULAKBAŞI, N. (2021). Canavan Disease and Recent Advances. Cyprus Journal of Medical Sciences, Cilt: 6 - Sayı: 3, 273–278. https://ajindex.com/articles/406895

📄 Tam Metin PDF Okuyucu

📄

PDF görüntüleyici hazırlanıyor...

Kaynakça (14)

  1. Sreenivasan P, Purushothaman KK. Radiological clue to diagnosis of Canavan disease. Indian J Pediatr. 2013
  2. 80(1):75-77. [CrossRef] 2. Lyon G, Fattal-Valevski A, Kolodny EH. Leukodystrophies: Clinical and genetic aspects. Top Magn Reson Imaging. 2006
  3. 17(4):219-242. [CrossRef] 3. Wijayasinghe YS, Pavlovsky AG, Viola RE. Aspartoacylase catalytic deficiency as the cause of Canavan disease: A structural perspective. Biochemistry. 2014
  4. 53(30):4970-4978. [CrossRef] 4. Baslow MH, Guilfoyle DN. Canavan disease, a rare earlyonset human spongiform leukodystrophy: Insights into its genesis and possible clinical interventions. Biochimie. 2013
  5. 95(4):946-956. [CrossRef] 5. Pleasure D, Guo F, Chechneva O, et al. Pathophysiology and treatment of Canavan disease. Neurochem Res. 2020
  6. 45(3):561-565. [CrossRef] 6. Bokhari MR, Samanta D, Bokhari SRA. Canavan disease. In Stat- Pearls. Treasure Island, FL: StatPearls Publishing, 2021. 7. Di Pietro V, Cavallari U, Amorini AM, et al. New T530C mutation in the aspartoacylase gene caused Canavan disease with no correlation between severity and N-acetylaspartate excretion. Clin Biochem. 2013
  7. 46(18):1092-1094. 8. Baslow MH, Hrabe J, Guilfoyle DN. Dynamic relationship between neurostimulation and N-acetylaspartate metabolism in the human visual cortex: Evidence that NAA functions as a molecular water pump during visual stimulation. J Mol Neurosci. 2007
  8. [CrossRef] 9. Hoshino H, Kubot M. Canavan disease: Clinical features and recent advances in research. Pediatr Int. 2014
  9. [Cross- Ref] 10. Hagenfeldt L, Bollgren I, Venizelos N. N-Acetylaspartic aciduria due to aspartoacylase deficiency: A new aetiology of childhood leukodystrophy. J Inherit Metab Dis. 1987
  10. [Database] [CrossRef] 11. Bluml S. in vivo quantitation of cerebral metabolite concentrations using natural abundance 13C MRS at 1.5 T. J Magn Reson. 1999
  11. [CrossRef] 12. Kumar S, Mattan NS, de Vellis J. Canavan disease: A white matter disorder. Ment Retard Dev Disabil Res Rev. 2006
  12. [Cross- Ref] 13. Madhavarao CN, Arun P, Moffett JR, et al. Defective Nacetylaspartate catabolism reduces brain acetate levels and myelin lipid synthesis in Canavan’s disease. Proc Natl Acad Sci USA. 2005
  13. [CrossRef] 14. Wang J, Leone P, Wu G, et al. Myelin lipid abnormalities in the aspartoacylase-deficient tremor rat. Neurochem Res. 2009
  14. [CrossRef] 15. Baslow MH. Brain N-acetylaspartate as a molecular water pump and its